SMSusan Matulevicius

Susan Matulevicius

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Susan Matulevicius has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Colby R. Ayers

    Donald W. Reynolds Cardiovascular Clinical Research Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-9047, USA

    3 shared publications
  • Anand Rohatgi

    University of Texas Southwestern Medical Center

    2 shared publications
  • Andres Deluna

    University of Texas Southwestern Medical Center

    2 shared publications
  • Angela L. Price

    University of Texas Southwestern Medical Center

    2 shared publications
  • Fernando Torres

    Division of Cardiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-9047, USA

    2 shared publications
  • Konstadina Darsaklis

    Division of Cardiology, Department of Internal Medicine, Hartford Hospital, 85 Jefferson Street, Suite 208, Hartford, CT, 06106-2602, USA

    2 shared publications

Latest Publications

  • Top Cited Papers

    Academic Medicine Faculty Perceptions of Work-Life Balance Before and Since the COVID-19 Pandemic

    by Susan A. Matulevicius, Kimberly A. Kho, Joan Reisch, Helen Yin

    The COVID-19 pandemic has altered the ways we live and work with far-reaching impacts on all sectors of society. In the United States, 9.8 million jobs were lost between February and December 2020.1 This job loss has disproportionately affected women, who accounted for 46% of the prepandemic workforce but have experienced 54% of pandemic-related job losses.2 Structural inequalities further affect parents who have significantly increased their time spent on household and childcare duties by an additional 27 hours per week.1 This change has disproportionately affected mothers of young children, who have experienced a 4- to 5-fold decrease in work hours than working fathers since the pandemic.3


  • Right atrial emptying fraction non-invasively predicts mortality in pulmonary hypertension

    by Konstadina Darsaklis, Matthew E. Dickson, William Cornwell, Colby R. Ayers, Fernando Torres, Kelly M. Chin, Susan Matulevicius

    Right-sided heart failure is the most common cause of death in pulmonary hypertension (PH). Echocardiographic measurements of right atrial (RA) size are associated with worse outcome in PH, however the association between RA function and death in PH has not been well-described. 160 PH patients (World Health Organization groups 1–5) underwent cardiac magnetic resonance imaging (cMRI) and right heart catheterization (RHC) within 6 weeks of each other at a tertiary care academic medical center in the United States. We measured cMRI RA maximum and minimum volumes indexed to body surface area and calculated RA emptying fraction (RAEF). We evaluated the relationship between RAEF and clinical variables with death using Cox proportional hazard models. 57 deaths occurred during a median follow-up of 3.5 years (36 % died overall, 10 % per year). RAEF was directly correlated in univariate analyses with right ventricular (RV) ejection fraction, left ventricular (LV) ejection fraction, LV size, cardiac index, absence of tricuspid and pulmonic regurgitation, absence of pericardial effusion, estimated glomerular filtration rate, 6-minute walk distance, and pulmonary arterial oxygen saturation, whereas it was inversely correlated with death, BNP, heart rate, mean RA pressure, mean PA pressure, pulmonary and systemic vascular resistance, RV size, and RA size. Using multivariate analyses, RAEF had a robust inverse association with death after adjusting for measured risk factors (HR per 5 % change in RAEF: 0.83 [95 % CI 0.73–0.94], p = 0.003). In PH patients, decreased RAEF by cMRI is independently associated with worse survival after adjustment for other risk factors.


  • The association of abnormal findings on transthoracic echocardiography with 2011 Appropriate Use Criteria and clinical impact

    by Thomas P. Koshy, Anand Rohatgi, Sandeep R. Das, Angela L. Price, Andres Deluna, Nicholas Reimold, Kyle Willett, Sharon C. Reimold, Susan A. Matulevicius

    Transthoracic echocardiography (TTE) Appropriate Use Criteria (AUC) were developed to promote high-value care. We describe the prevalence of clinically significant abnormal TTE findings overall and in subgroups defined by appropriate and inappropriate AUC, and their association with clinical impact. 548 consecutive TTEs at an academic medical center were retrospectively reviewed for AUC, clinical impact, and TTE abnormalities. TTE reports within 1 year of the index TTE were reviewed to determine if abnormalities were new, unchanged, or resolved. Clinical impact was classified into no change, active change, or continuation of care. 91 % of TTEs were appropriate, 5 % were inappropriate, and 4 % were uncertain by AUC. 46 % of all TTEs and 57 % of first-time TTEs had no significant TTE abnormalities. Appropriate TTEs had a higher prevalence of ≥1 TTE abnormality than inappropriate TTEs (56 vs. 33 %, p = 0.029). Among repeat TTEs, 72 % had ≥1 TTE abnormality, however only 25 % had a new abnormality. The prevalence of a new abnormality was similar between inappropriate and appropriate repeat TTEs (25 vs. 26 %, p = 1.0). The prevalence of ≥1 abnormality was similar between TTEs that resulted in active change and no change in care (70 vs. 64 %, p = 0.06). Although most TTEs were appropriate as defined by AUC, the majority had no significant abnormalities. Although most TTEs were appropriate by AUC, >50 % of all TTEs and 25 % of repeat TTEs had no significant abnormalities. Appropriate TTEs had a higher prevalence of abnormalities, however the prevalence of abnormalities was similar between TTEs that resulted in active change versus no change in care.


  • Appropriate Use and Clinical Impact of Transthoracic Echocardiography

    by Susan A. Matulevicius, Anand Rohatgi, Sandeep R. Das, Angela L. Price, Andres Deluna, Sharon C. Reimold

    Research from JAMA Internal Medicine — Appropriate Use and Clinical Impact of Transthoracic Echocardiography


  • CARDIAC MRI PREDICTORS OF MORTALITY IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION

    by Konstadina Darsaklis, Mariella Vélez-Martinez, Susan Matulevicius, Sonja Bartolome, Fernando Torres, Kelly Chin


  • Potential of Electron Beam Computed Tomography for Coronary Artery Calcium Screening to Evaluate Fatty Liver: Comparison with 1H Magnetic Resonance Spectroscopy in the Dallas Heart Study

    by Susan Matulevicius, Laura C. Huff, Lidia S. Szczepaniak, Colby R. Ayers, Matthew Budoff, Roderick McColl, Amit Khera, Ronald M. Peshock

    Objectives: Electron beam computed tomography (EBCT) for coronary artery calcification can potentially evaluate liver fat, another marker of cardiovascular risk. We compared quantitative estimates of hepatic steatosis measured by EBCT with those obtained by a well-validated, accurate-measure, magnetic resonance spectroscopy (1H MRS). Methods: EBCT and 1H MRS were performed in 2159 subjects from the Dallas Heart Study. Forty subjects were randomly selected from each of 5 subgroups of liver fat percent by 1H MRS (n = 200). EBCT average liver attenuation (HU) was determined in a 1- to 2-cm circular region of interest over the liver lobes. Pearson correlation coefficients were calculated. Using a previously defined 1H MRS hepatic steatosis cut point (>5.5%), an optimized EBCT liver attenuation cut point was determined by receiver operating characteristic analysis. Results: 1H MRS liver fat content and EBCT average right lobe liver attenuation were moderately negatively correlated ( r = −0.64, P < 0.0001) in all subjects and in those with 1H MRS hepatic steatosis ( r = −0.71, P < 0.0001). This correlation did not improve with attenuation correction of the EBCT data using a standard calcium phantom or statistical transformation. Using an optimized receiver operating characteristic EBCT cut point (64.5 HU), sensitivity was 78% and specificity was 72% for detecting 1H MRS hepatic steatosis, with a high false negative rate. Risk factors for hepatic steatosis (obesity, diabetes mellitus, insulin resistance, metabolic syndrome) were more strongly correlated with 1H MRS than EBCT liver fat measures. Conclusions: Liver attenuation on EBCT acquired for coronary artery calcification screening correlates modestly with 1H MRS measures of liver fat content, with a high false negative rate.


  • THE POTENTIAL OF EBCT FOR CORONARY ARTERY CALCIUM SCREENING TO EVALUATE FATTY LIVER: DALLAS HEART STUDY

    by Susan Matulevicius, Laura C. Huff, Colby R. Ayers, Roderick McColl, Lydia Sczcepaniak, Amit Khera, Ronald M. Peshock